4//SEC Filing
Simon Nicholas 4
Accession 0001567619-18-003534
CIK 0001656634other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:23 PM ET
Size
12.1 KB
Accession
0001567619-18-003534
Insider Transaction Report
Form 4
Simon Nicholas
Director10% Owner
Transactions
- Conversion
Series A Convertible Preferred Stock
2018-10-02−1,565,216→ 0 total(indirect: See Footnote 1)→ Common Stock (1,565,216 underlying) - Purchase
Common Stock
2018-09-28$15.00/sh+333,333$4,999,995→ 333,333 total(indirect: See Footnote) - Conversion
Common Stock
2018-10-02+2,234,112→ 2,567,445 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2018-10-02−668,896→ 0 total(indirect: See Footnote)→ Common Stock (668,896 underlying)
Footnotes (3)
- [F1]Consists of the shares held by Clarus Lifesciences III, L.P. ("Clarus"). Clarus Ventures III GP, L.P. ("GPLP"), as the sole general partner of Clarus may be deemed to beneficially own certain of the shares held by Clarus. The GPLP disclaims beneficial ownership of all shares held by Clarus in which the GPLP does not have an actual pecuniary interest. Clarus Ventures III, LLC ("GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held by Clarus. The GPLLC disclaims beneficial ownership of all shares held by Clarus in which it does not have an actual pecuniary interest. The Reporting Person, as an individual managing director of GPLLC disclaims beneficial ownership of all shares held of record by Clarus in which he does not have an actual pecuniary interest.
- [F2]The Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- [F3]The Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
Documents
Issuer
Gritstone Oncology, Inc.
CIK 0001656634
Entity typeother
Related Parties
1- filerCIK 0001431403
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:23 PM ET
- Size
- 12.1 KB